Hani Duglof, a 33-year-old asylee from Libya, was detained by ICE for six days in January 2023. Duglof came to the United States seeking an experimental bone marrow transplant for his rare genetic skin condition, epidermolysis bullosa (EB), but was denied eligibility for the treatment. His case underscores the potential negative impact of aggressive immigration enforcement on the U.S. biotechnology sector, particularly for research involving rare diseases.
Key Details:
- Duglof was detained by ICE in January 2023 for six days.
- He sought asylum in the U.S. after fleeing civil war in Libya.
- Duglof and his brother participated in research that contributed to the development of a multi-million dollar gene therapy, Zevaskyn.
- Experts warn that such detentions can hinder biotech research reliant on diverse patient populations.
The detention of individuals like Duglof poses significant challenges for researchers and companies focused on rare diseases, impacting their ability to conduct vital studies. Need help with your immigration case? Visit QuickFiling.us for professional immigration services.
Source: Turna Ray